文献速递心力衰竭与心肌病

慢性心衰急性加重患者心脏康复效果及Humanin/CRP比值预后价值

[Effects of cardiac rehabilitation and predictive value of Humanin/CRP ratio in patients with acute exacerbation of chronic heart failure].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2026-01-01

本研究为非随机回顾性队列研究,纳入154例慢性心力衰竭急性加重期住院患者,评估标准化康复方案对体能、运动耐力及预后的影响,并探讨血清Humanin/CRP比值的预后风险分层价值。康复干预组出院时简易体能状况量表评分和6分钟步行距离均优于对照组,MACE发生率有降低趋势但差异无统计学意义。Humanin/CRP比值与MACE风险呈负相关,但单独用于风险分层的判别能力有限。

要点

  • 标准化康复可改善慢性心衰急性加重患者出院时体能状况和运动耐力。
  • 康复干预组MACE发生率为34%,较对照组49%有降低趋势,但未达统计学显著。
  • Humanin/CRP比值与MACE风险呈负相关,单独判别能力有限,需结合其他指标。

核心结论

  • 标准化康复治疗可有效改善慢性心力衰竭急性加重期住院患者的体能状况和运动耐力,MACE有降低趋势。
  • Humanin/CRP比值与MACE风险呈负相关,但其单独用于风险分层的判别能力有限,需结合其他临床指标综合评估。

研究设计与样本

  • 非随机分组的回顾性队列研究。
  • 连续纳入2025年3至11月南京医科大学第三附属医院收治的慢性心力衰竭急性加重期住院患者,共154例。
  • 依据住院期间是否实施心脏康复治疗分为康复干预组71例和对照组83例。
  • 康复干预组在常规药物治疗基础上接受涵盖主被动运动、呼吸肌训练及营养支持等的综合管理。
  • 出院后随访6个月,比较两组MACE发生率。

主要发现

  • 康复干预组简易体能状况量表评分为9(8,9)分,优于对照组的8(7,9)分,P=0.001。
  • 康复干预组6分钟步行距离为309(271,344)m,优于对照组的293(222,315)m,P=0.026。
  • 康复干预组MACE发生率为34%(24/71),对照组为49%(41/83),绝对风险降低15%,但差异无统计学意义(P=0.051)。
  • 多因素Cox回归显示Humanin/CRP比值与MACE风险呈负相关,HR=0.999,95%CI:0.998~1.000,P=0.011。
  • 低Humanin/CRP比值亚组6个月累积无MACE生存率低于高比值亚组,log-rank P=0.008。

关键数值与推荐

  • Humanin/CRP比值预测MACE的受试者工作特征曲线分析显示敏感度为92.5%,特异度为27.5%。

临床怎么用

  • 对慢性心力衰竭急性加重期住院患者可考虑实施包含主被动运动、呼吸肌训练和营养支持的标准化康复方案。
  • Humanin/CRP比值不宜作为单独的风险分层指标,应与其他临床参数结合使用。

局限性

  • 非随机分组的回顾性队列设计,存在选择偏倚和混杂因素可能。
  • Humanin/CRP比值单独用于风险分层的判别能力有限,特异度较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the effects of a standardized rehabilitation protocol on physical performance, exercise tolerance, and prognosis in hospitalized patients with acute exacerbation of chronic heart failure (CHF), and to explore the clinical value of the serum Humanin (a mitochondria-derived peptide) to C-reactive protein (CRP) ratio in prognostic risk stratification. Methods: This non-randomized retrospective cohort study consecutively enrolled patients with acute exacerbation of CHF admitted to the Third Affiliated Hospital of Nanjing Medical University from March to November 2025. Patients were divided into a rehabilitation intervention group and a control group according to whether standardized rehabilitation was implemented. The rehabilitation intervention group received comprehensive management including active and passive exercise, respiratory muscle training, and nutritional support in addition to conventional pharmacological therapy. Baseline data including age and sex were collected, and serum Humanin and CRP levels were measured to calculate the Humanin/CRP ratio. Physical performance at discharge was assessed using the short physical performance battery score and the 6-minute walk test. Patients were followed up for 6 months after discharge, and the incidence of major adverse cardiovascular events (MACE) was compared between the two groups. Multivariate Cox regression was used to analyze independent risk factors for MACE. The key variable identified from the multivariate Cox regression model (Humanin/CRP ratio) was used to construct a receiver operating characteristic curve. Kaplan-Meier survival curves were plotted for the low and high Humanin/CRP ratio subgroups, and between-group comparisons were performed using the log-rank test. Results: A total of 154 hospitalized patients with acute exacerbation of CHF were enrolled, with a median age of 76 (68, 82) years and 64 (42%) males. The rehabilitation intervention group comprised 71 patients and the control group comprised 83 patients. The rehabilitation intervention group showed higher short physical performance battery scores (9 (8, 9) vs. 8 (7, 9), P=0.001) and 6-minute walk distance (309 (271, 344) m vs. 293 (222, 315) m, P=0.026) compared with the control group. The MACE incidence in the rehabilitation intervention group was 34% (24/71), representing an absolute risk reduction of 15% compared with 49% (41/83) in the control group; however, the difference was not statistically significant (P=0.051). Multivariate Cox regression analysis showed that Humanin/CRP ratio was negatively correlated with MACE risk (HR=0.999, 95%CI: 0.998-1.000, P=0.011). Receiver operating characteristic curve analysis indicated that the ratio predicted MACE with a sensitivity of 92.5% and a specificity of 27.5%. Kaplan-Meier survival curves demonstrated that the 6-month cumulative MACE-free survival rate was significantly lower in the low Humanin/CRP ratio subgroup than in the high ratio subgroup (log-rank P=0.008). Conclusions: Standardized rehabilitation therapy effectively improves physical performance and exercise tolerance in hospitalized patients with acute exacerbation of CHF, with a trend toward reduced MACE. Although the Humanin/CRP ratio was inversely associated with MACE risk, its discriminatory ability for risk stratification as a standalone indicator is limited, and it should be evaluated in conjunction with other clinical parameters. 目的: 评估标准化康复方案对慢性心力衰竭急性加重期住院患者体能状况、运动耐力及预后的改善作用,并探讨血清Humanin(一种线粒体衍生肽)与C反应蛋白(CRP)比值在预后风险分层中的临床价值。 方法: 本研究为非随机分组的回顾性队列研究,连续纳入2025年3至11月南京医科大学第三附属医院收治的慢性心力衰竭急性加重期住院患者。依据住院期间是否实施心脏康复治疗分为康复干预组与对照组。康复干预组在常规药物治疗基础上,接受涵盖主被动运动、呼吸肌训练及营养支持等的综合管理。收集两组的年龄、性别等基线资料,检测基线血清Humanin、CRP水平并计算Humanin/CRP比值。采用简易体能状况量表评分及6 min步行试验评估两组患者出院时身体活动功能。出院后随访6个月,比较两组的主要不良心血管事件(MACE)发生率,采用多因素Cox回归分析MACE的独立危险因素,对多因素Cox回归模型筛选出的关键变量(Humanin/CRP比值)构建受试者工作特征曲线,采用Kaplan-Meier法绘制低Humanin/CRP比值组和高Humanin/CRP比值组的生存曲线,并采用log-rank检验进行组间比较。 结果: 共纳入154例慢性心力衰竭急性加重期住院患者,年龄76(68,82)岁,男性64例(42%),康复干预组71例,对照组83例。康复干预组简易体能状况量表评分[9(8,9)分比8(7,9)分,P=0.001]与6 min步行距离[309(271,344)m比293(222,315)m,P=0.026]均优于对照组。康复干预组MACE发生率为34%(24/71),较对照组49%(41/83)绝对风险降低15%,但差异无统计学意义(P=0.051)。多因素Cox回归显示,Humanin/CRP比值与MACE风险呈负相关(HR=0.999,95%CI:0.998~1.000,P=0.011)。受试者工作特征曲线分析表明,该比值预测MACE的敏感度为92.5%,特异度为27.5%。Kaplan-Meier生存曲线显示,低Humanin/CRP比值亚组6个月累积无MACE生存率低于高比值亚组(log-rank P=0.008)。 结论: 对慢性心力衰竭急性加重期住院患者的标准化康复治疗可有效改善其体能状况和运动耐力,MACE有降低趋势。Humanin/CRP比值与MACE风险呈负相关,但其单独用于风险分层的判别能力有限,需结合其他指标综合评估。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li, Zhang, Yang, et al. [Effects of cardiac rehabilitation and predictive value of Humanin/CRP ratio in patients with acute exacerbation of chronic heart failure]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 42736132. doi:10.3760/cma.j.cn112148-20260515-00320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。